ReviewIndian journal of microbiology2024
Microbial Bacterioruberin: A Comprehensive Review.
Review in Indian journal of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Carotenoids of Halophilic Archaea: Production, Properties and Biotechnological Applications.Probiotics and antimicrobial proteins · 2026Review
- Bacterioruberin fromInternational journal of molecular sciences · 2026Article
- A New Era for Using Natural Pigments: The Case of the CBiotechnology and applied biochemistry · 2026Review
- Characterization and Functional Evaluation of Carotenoids From Haloarcula rubripromontorii BS2.MicrobiologyOpen · 2026Article
- Microbial conversion of biodiesel waste for carotenoid production.Frontiers in bioengineering and biotechnology · 2026Article
- Bacterioruberin (CNutrients · 2025Review
- Application of bacterioruberin fromFood chemistry. Molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterioruberin (BR) is a fat-soluble, dipolar, reddish pigment predominantly found in halophilic archaea. BR is a rare C50 carotenoid from the xanthophyll family, and it has been extensively studied for its potent antioxidant properties, such as its ability to protect cells from oxidative stress. In addition, several studies have shown that BR-rich extracts and its derivatives exhibit significant antiviral, antidiabetic, antibacterial, and anti-inflammatory effects, making them ideal candidates for the development of novel therapeutic interventions against various diseases. Although it possesses remarkable biological properties, studies related to the regulatory aspects of biosynthesis, in vitro and in vivo studies of purified BR have been rare. However, investigations are needed to explore the potential application of BR in various industries. Additionally, optimization of the culture conditions of BR-producing haloarchaea could pave the way for their sustainable production and utilization. The current review provides comprehensive information on BR, which includes the sources of this compound and its bioproduction, extraction, stability, toxicity, and biological activities in relation to its commercial applications. This review also discusses the potential challenges and limitations associated with BR bioproduction and its utilization in various industries. In addition, this treatise highlights the need for further research to optimize production and extraction methods and explore avenues for novel applications of BR in various sectors, such as pharmaceuticals, food, and cosmetics. Graphical Abstract:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.